Diagnostic modalities in cutaneous leishmaniasis

Authors

  • Arfan ul Bari
  • Simeen Ber Rahman

Keywords:

Cutaneous leishmaniasis, parasitological diagnosis, immunodiagnosis, serological tests

Abstract

Cutaneous leishmaniasis is a protozoan disease caused by various species of an obligate intracellular parasite Leishmania. It is endemic in more than 80 countries on five continents; Africa, Asia, Europe, North America and South America, with a total of 350 million people at risk. In view of the large number of clinical presentations of cutaneous leishmaniasis (CL), a correct diagnosis of the disease becomes important. Clinical appearance along with history of visit to an endemic area may be sufficient at times. These days the diagnosis is generally aided by slit skin smear and impression smears examination, histopathology of the tissue sections and by culture of parasite. However, unusual clinical presentation, superadded infection or persistence of the disease for a prolonged time, has provoked scientists to develop more sensitive methods to detect even a trace of the parasite. The present article is to review the various diagnostic techniques and their relevance in different clinical settings. 

References

Grevelink SA, Lerner EA. Leishmaniasis. J Am Acad Dermatol 1996; 34: 257-72.

Berman JD: Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin Infect Dis 1997; 24: 684-703.

Dowlati Y. Cutaneous leishmaniasis. Clinical aspects. Clin. Dermatol 1996; 14: 425-31.

Mujtaba G, Khalid M. Cutaneous leishmaniasis in Multan, Pakistan. Int J Dermatol 1998; 37: 843-6.

Ridley DS. The laboratory diagnosis of tropical diseases: Review. J Cl Path 1974; 27: 435-44.

Bergan RS. Leishmania, touch preparation as a rapid mean of diagnosis. J Am Acad Dermatol 1986; 16: 1096-1105.

Sharquie KE, Hassen AS, Hassan SA, Al-Hamami IA. Evaluation of diagnosis of cutaneous leishmaniasis by direct smear, culture and histopathology. Saudi Med J 2002; 23: 925-8.

Shatry AM, Oster CN, Mebrahtu YB et al. Mouse foot pad inoculation as an aid to isolation of Leishmania species. Trans R Trop Med Hyg 1988; 82: 701-3.

Manuel J, Behin R, eds. Immunology of parasitic infections, 2nd edn. Sidney: Cotton and Kenneth Swarren; 1982.

Kenner JR, Aronson NE, Bratthauer GL et al. Immunohistochemistry to identify Leishmania parasites in fixed tissues. J Cutan Pathol 1999; 26: 130-6.

Safaei A, Motazedian MH, Vasei M. Polymerase chain reaction for diagnosis of cutaneous leishmaniasis in histologically positive, suspicious and negative skin biopsies. Dermatology 2002; 205: 18-24.

Kern P. Leishmaniasis. Antibiotic Chemotherapeutics 1981; 30: 203-23.

Alkhawaja AM, Larbi E, Al-Gindan Y et al. Treatment of cutaneous leishmaniasis with antimony: intramuscular vs. intralesional administration. Ann Trop Med Parasitol 1997; 91: 899-905.

Lai A, Fat EJ, Vrede MA et al. Pentamidine, the drug of choice for the treatment of cutaneous leishmaniasis in Surinam. Int J Dermatol 2002; 41: 796-800.

Kubba R, Al-Gindan Y, El-Hassan AM, Omer AHS. Ketoconazole in cutaneous leishmaniasis: results of a pilot study. Saudi Med J 1986; 7: 596-604.

Ganor S. The treatment of leishmaniasis residuals with local injections of amphotericin B. Dermatol Int 1967; 6: 141-3.

Herwaldt BL: Leishmaniasis. Lancet 1999; 354: 1191-9

Al-Jitawi SA, Farraj SE, Ramahi SA. Conventional scraping versus fine needle aspiration cytology in the diagnosis of cutaneous leishmaniasis. Acta Cytol 1995; 39:82-4.

Ridley DS. A histological classification of cutaneous leishmaniasis and its geographical expression. Trans R Soc Trop Med Hyg 1980; 74: 515-19.

World Health Organisation. Leishmaniasis 12th programme report of TDR 1995.

Radwanski ZK, Bryceson ADM, Preston PM et al. Immunofluorescence studies in L. enrietti infection in guinea pig. Trans R Soc Trop Med Hyg 1974; 68: 124-32.

Voller A, Bidweil D. Antigen detection by ELISA. Asean J Clin Sci 1985; 5; 121-3.

Follador I, Araujo C, Bacellar O, et al. Epidemiologic and immunologic findings for the subclinical form of Leishmania braziliensis infection. Clin Infect Dis 2002; 34: 54-8.

Ryan JR, Smithyman AM, Rajasekariah GH et al. Enzyme-linked immunosorbent assay based on soluble promastigote antigen detects immunoglobulin M (IgM) and IgG antibodies in sera from cases of visceral and cutaneous leishmaniasis. J Clin Microbiol 2002; 40: 1037-43.

Schubach A, Cuzzi-Maya T, Oliviera AV et al. Leishmanial antigens in the diagnosis of active lesions and the ancient scars of American tegumentary leishmaniasis patients. Mem Inst Oswaldo Cruz 2001; 96: 987-96.

Anders G, Eisenberger CL, Jonas F, Greenblatt CL. Distinguishing Leishmania tropica and L. major in the Middle East using the polymerase chain reaction with kinetoplast DNA-specific primers. Trans R Soc Trop Med Hyg 2002; 96 (Suppl 1): S87-92.

Monroy-Ostria A, Sanchez-Tejeda G. Molecular probes and the polymerase chain reaction for detection and typing of Leishmania species in Mexico. Trans R Soc Trop Med Hyg 2002; 96 (Suppl 1): S101-4.

Rahman SB, Aziz T, Kaker M et al. Strain characterization of the local isolates of Leishmania from cutaneous leishmaniasis using monoclonal antibodies. Pak J Pathol 1998; 9: 18-9.

Rab M, Al Rustamani L, Bhutta R et al. Cutaneous leishmaniasis: iso-enzyme characterization of Leishmania tropica. J Pak Med Assoc 1997; 47: 270-3.

Downloads

Published

2017-01-03

How to Cite

1.
Bari A ul, Rahman SB. Diagnostic modalities in cutaneous leishmaniasis. J Pak Assoc Dermatol [Internet]. 2017Jan.3 [cited 2024Apr.18];14(2):81-6. Available from: http://jpad.com.pk/index.php/jpad/article/view/787

Issue

Section

Review Articles

Similar Articles

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)

1 2 3 4 5 > >>